Scarica l'app Stockscreener
94.62
4.51%
4.08
Dopo l'orario di chiusura:
96.07
1.45
+1.53%
Precedente Chiudi:
$90.54
Aprire:
$100.1
Volume 24 ore:
4.67M
Relative Volume:
2.75
Capitalizzazione di mercato:
$12.66B
Reddito:
$2.51B
Utile/perdita netta:
$185.56M
Rapporto P/E:
70.61
EPS:
1.34
Flusso di cassa netto:
$517.59M
1 W Prestazione:
+8.37%
1M Prestazione:
+6.31%
6M Prestazione:
+67.17%
1 anno Prestazione:
+9.32%
Intervallo 1D:
$94.02
$101.40
Intervallo di 1 settimana:
$85.65
$101.40
Portata 52W:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Confronta GMED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
94.62 | 12.12B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
126.18 | 220.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.38 | 146.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.21 | 140.64B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.69 | 127.91B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.23B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-11-07 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-28 | Ripresa | Stifel | Hold |
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
Can Globus Medical Inc. stock maintain growth trajectoryTrade Exit Summary & Entry Point Confirmation Signals - ulpravda.ru
Why Globus Medical Inc. stock could benefit from AI revolution2025 Top Gainers & Community Shared Stock Ideas - ulpravda.ru
Will Globus Medical Inc. stock benefit from automationNew Guidance & Stock Portfolio Risk Control - ulpravda.ru
Insider plans sale of 3,594 common shares under Rule 144 | GMED SEC FilingForm 144 - Stock Titan
GMED (GMED) holder files to sell 2,000 shares after RSU vesting - Stock Titan
Is Globus Medical Inc. stock dividend yield sustainableQuarterly Trade Report & Expert Curated Trade Ideas - ulpravda.ru
Globus Medical jumps 9% after upbeat revenue and earnings outlook - Yahoo Finance
Globus Medical (GMED) Price Target Raised to $115.00 by Piper Sa - GuruFocus
Globus Medical stock hits all-time high at 99.5 USD By Investing.com - Investing.com Canada
Globus Medical climbs on better-than-expected Q4, FY outlook - TradingView — Track All Markets
US-based Globus Medical anticipates 25.2% sales increase in Q4 2025 - Medical Buyer
Citizens reiterates Market Perform rating on Globus Medical stock By Investing.com - Investing.com Canada
Globus Medical (GMED) Surges on Strong Sales Projections - GuruFocus
Jon Najarian: Globus Medical shares surge 9 percent on strong Q4 sales projection - Traders Union
Jefferies raises Globus Medical stock price target to $115 on strong Q4 - Investing.com Canada
Why Globus Medical Stock Is Flying Higher in After-Hours Trading - The Globe and Mail
Globus Medical Surges On Preliminary Q4 And FY25 Sales Results; Issues FY26 Guidance - Nasdaq
Globus Medical Stock Pre-Market (+9.3%): Strong Prelim Q4 Sales & Upbeat 2026 Guidance - Trefis
Globus Medical reports 25.2% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Globus Medical (GMED) Projects Strong Revenue Growth for 2025 - GuruFocus
GMED Sees Strong Q4 Results, Eyes Growth in 2026 - GuruFocus
Globus Medical Q4 Preliminary Sales Rise 25% From Year Earlier; Shares Jump After Hours - MarketScreener
GMED Stock Sees Significant Annual Growth - GuruFocus
GMED Raises Revenue Forecast for FY26 - GuruFocus
Globus Medical reports 25.2% revenue growth in Q4 2025 - Investing.com India
Globus Medical's preliminary Q4 sales beat estimates - TradingView — Track All Markets
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results - The Manila Times
Globus Medical (GMED) shares preliminary 2025 sales results and 2026 guidance - Stock Titan
Globus posts record 2025 sales, sets 2026 revenue guidance up to $3.22B - Stock Titan
Stifel raises Globus Medical stock price target to $90 on strong outlook - Investing.com Canada
Will Globus Medical Inc. stock attract ESG investors2026 world cup usa national team qualification top scorers counter attacking winner prediction tactical review - ulpravda.ru
Globus Medical (GMED) director gifts 6,100 Class A shares, updates holdings - Stock Titan
Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A - TradingView — Track All Markets
Does Globus Medical (NYSE:GMED) Deserve A Spot On Your Watchlist? - Yahoo Finance
Allspring Global Investments Holdings LLC Acquires 312,149 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Globus Medical Inc: The Spine Stock Wall Street Slept On (Until Now) - AD HOC NEWS
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates - sharewise.com
The Truth About Globus Medical Inc: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
Fort Washington Investment Advisors Inc. OH Raises Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Listed in NYSE Composite Healthcare Group - Kalkine Media
Should I hold or sell Globus Medical Inc. stock in 2025Debt-to-Equity Ratio Analysis & Free High Yield Investment Strategies - bollywoodhelpline.com
Globus Medical, Inc. $GMED is Paradice Investment Management LLC's Largest Position - MarketBeat
BTIG reiterates Neutral rating on Globus Medical stock after strong Q3 - Investing.com Canada
Audubon’s Globus Medical Makes Game-Changing Acquisition - MSN
Boston Trust Walden Corp Takes $67.89 Million Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Globus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - FinancialContent
Swedbank AB Increases Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED): Assessing Valuation After a 60% Three-Month Share Price Surge - Sahm
Globus Medical (STU:GM0N) EV-to-OCF : 15.30 (As of Dec. 24, 2025) - GuruFocus
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):